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It has been progressively clarified that specific genes have influence on the occurrence, treatment, 
and prevention of various diseases, and genes and genomes have become more involved in every 
field of medicine. Conventional therapies now involve genetic study of the occurrence 
mechanism of cancer, therapeutic effects of anticancer drugs, and susceptibility to a specific 
cancer by performing gene analysis of cancer cells removed from a body. It has been revealed 
that specific genes promote or suppress the occurrence of some types of diseases, and clinical 
testing of gene therapy for providing a body with necessary genes is being conducted around the 
world. In reproductive medicine, it is now possible for parents to determine whether to have a 
baby by checking the genetic qualities (genome, gene, chromosome, and biochemical features) 
of the parents-to-be and the child-to-be. Genes, sometimes called “a design of life,” have become 
in such fields a target of manipulative intervention (selection, modification, addition, and 
removal) based on data obtained from testing and diagnosing. 
Clinical medicine is required to respect the requests and intent of patients or clients, as is the 
case with other medicines. Medical treatment is conducted in line with the diverse emotions of 
patients or clients such as pain, fear, expectation, and hope. In particular, when there is a 
connection between genes and occurrence, treatment, and prevention of diseases, it is usually 
difficult to treat the disease using general principles and manuals. Therefore, an appropriate 
communication process is needed to solve the problem and determine a specific strategy in line 
with each individual case, taking full account of the values and preferences of the individuals 
involved. 
The intent and emotion of patients or clients are regarded in most cases as a leading factor 
for setting the direction of the decision-making process. In such a process, taking account of why 
and how the intent and emotion were developed, i.e. the context surrounding each case is 
indispensable. We can describe the context as various multi-layered vectors that work 
dynamically in clinical medicine. To be more specific, the dominant concept of values in a 
community, the choice of the majority of people, and the system conditions can have an impact 
on decisions in each area of clinical medicine, and, on the contrary, individual decision can 
encourage and reproduce the current situation of society and in particular people’s concept of 
values. The relation between face-to-face communication and reflective or public 
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communication in clinical medicine is also a problem. 
In this article, I formulate these views using a context-sensitive approach to genetic 
medicine and organize them based on genetic counseling. Then I confirm the role and 
significance of context views and summarize the necessary points of the argument. Based on this 
work, I study the ethical issues of genetic medicine in consideration of preventing genetic 
diseases in reproduction (by genetic diagnosis at the premarital, preconception, preimplantation 
and prenatal stages). In the concluding section, I show the significance of context-sensitive 
approach to genetic medicine. 
 
 
1. Context-sensitive Approach to Genetic Medicine: In line with Genetic Counseling 
 
There are various types of communications in clinical medicine for solving the problems people 
face and determining strategies. Genetic counseling is a typical example of such 
communications and is defined in general as follows; 
Genetic counseling is a communication process which deals with the human problems 
associated with the occurrence, or the risk of occurrence, of a genetic disorder in the family. This 
process involves an attempt by one or more appropriately trained persons to help the individual 
or family to 
1. Comprehend the medical facts, including the diagnosis, probable course of the disorder, and 
the available management; 
2. Appreciate the way heredity contributes to the disorder, and the risk of recurrence in specified 
relatives; 
3. Understand the alternatives for dealing with the risk of occurrence; 
4. Select a course of action which seems to them appropriate in view of their risk, their family 
goals, and their ethical and religious standards, to act in accordance with that decision; and 
5. Make the best possible adjustment to the disorder in an affected family member and/or the risk 
of recurrence of that disorder.1 
Clients undergoing genetic counseling have a variety of reasons. For example, some visit 
before marriage or pregnancy suspecting that their prospective children may develop a genetic 
disorder since a sibling has one; some visit before implantation or natality to avoid the possibility 
of them giving birth to babies with chromosomal abnormalities; and some visit before the 
occurrence of a genetic disorder to examine the possibility of them sharing the same fate as that 
                                                 
1  cf. American Society of Human Genetics Ad Hoc Committee on Genetic Counseling,  Genetic 
Counseling, American Journal of Human Genetics, 27:240-242,1975; “Genetic counseling, ethical issues 
in,” S.G.Post(ed.), Encyclopedia of Bioethics, 3rd ed., Macmillan, pp.948-952, 2004. 
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of their parents who died from a monogenic disease. 
Genetic counseling is a communication process focusing on the conversation with these 
clients, and it has the following essential principles: "Norms of nondirectiveness: providing 
balanced or unbiased information, not imposing specific values or options on the clients," 
"Empathetic understanding of a client's anxiety, fear or suffering," and "Respect for autonomy 
and support of the informed decision making of the client." Medical personnel who conduct the 
counseling (clinical genetic specialists or genetic counselors) present necessary medical 
information to the clients and families such as family history of the disease, clinical history of 
the client, the percentage of genetic cause of the disease occurrence, possibility of being a gene 
carrier, risk of passing the gene to children, applicability, cost and anticipated result of the 
genetic test. They then determine clear strategy by taking account of economic conditions and 
family relationship as well as the intent of the clients and families. They listen attentively to the 
fears and concerns of the clients and support their autonomous decisions made based on 
unbiased information. It is a communication process toward decisions that are made aiming for 
specific problem solving and strategy making. 
Now let me focus on some actual examples of the intent and emotion of the clients and raise 
possible issues, with which I would like to present several contexts surrounding “the 
autonomous choice and determination.” 
 
“I’m afraid that my engagement will be broken off if the test result reveals that I am a 
carrier of a genetic disease and my fiancée gets to hear of it.”  
”I would like to have a healthy baby through in vitro fertilization and conducting a 
genetic test since people tend to shun children with disabilities.” 
”Children with incurable diseases would be unable to live after the death of us parents, 
and therefore, even though we feel bad, we would choose an abortion if a genetic test 
detected an abnormality.” 
 
Various responses would be made to these concerns of the clients in the counseling session. 
In this context, the following questions could be raised. 
 
*Should we affirm the “pain” and “fear” of the clients as their psychological facts? 
Wouldn’t it be necessary to ask how they came to formulate such an opinion in the first 
place and whether the emotion arose due to a biased view and lack of knowledge and 
information? 
*Shouldn’t we take account of the social impact of choice as well as the concept of 
values that support the choice in each area of clinical medicine, particularly the choice to 
allow specific lives to die? Could we ignore criticism that the choice would reinforce the 
discrimination of persons with disabilities and promote the eugenic way of thinking? 
*What information should medical personnel provide in addition to medical information? 
For example, information on social support systems for people with disabilities or 
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incurable diseases, information and claims of the persons involved, actual condition and 
theoretical or practical study of discrimination against disabled persons, etc. 
*When medical personnel and client have the same opinion, the problem is “solved” and 
“smooth determination of strategy” is feasible. However, if the medical personnel lack 
understanding or have a biased view, would this be acceptable? 
 
The “intent” and “emotion” the clients express should definitely be a realistic appeal even if 
they are based on insufficient information and biased views. They could be an earnest claim with 
no other choices, involuntary choice, or difficult decision. Medical personnel are not allowed to 
deny or demand a retraction of the choice the clients make, but should respect in principle the 
right to self-determination and the freedom of choice of the clients. Nonetheless, if the above 
questions are considered as an infringement and interference of the autonomy of the clients and 
turned down, various multi-layered meanings of the “emotion” and in particular of the “pain” 
could be overlooked. 
 
 
2. Various Forces surrounding Clinical Settings of Genetic Medicine: Frame of Context-sensitive 
Approach 
 
Here, with regard to evaluation, judgment, choice, and determination when facing individual 
intent and emotion and specific issues in clinical medicine, I organize the context as a factor that 
supports and contributes to such considerations. 
 
(1) Influence of the general concept of values and system conditions in society on individual 
choice and determination:  
The “pain” and “fear” shown with actual examples in the preceding section assume that 
“engagement to a woman who may bear a child with a genetic disease will be broken,” that 
“disabled people will be shunned by people,” and that “patients with incurable diseases will have 
to struggle to live if they have no supportive family.” Are these assumptions evident “facts”? 
Shouldn’t we ask how such thoughts came to be formulated in the first place and whether these 
thoughts are the only ones that people could have? It is in fact a prevailing perspective that, 
although in an ideal world people should not be treated unfairly with discrimination or biased 
views even though they have a disability or incurable disease, real life is harsh. However, we 
cannot derive from such a perspective the conclusion that we must embrace real life as an 
unavoidable reality. We should focus on the discrimination and prejudice that run deep within 
general public, the mechanics of exclusion and avoidance in society against people with 
disabilities or incurable diseases, and insufficient support in their lives (medical care, welfare, 
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education, employment, etc). We then need to examine the influence of these factors on the 
choice and the determination in each area of clinical medicine. 
(2) Influence of individual choice and determination on society as a whole:  
If choices and decisions made in clinical genetic medicine accompany assessment and 
judgment of “value and quality of life,” they could have an impact on social systems and policies 
and people’s daily practice. Of course, most of the parties involved do not have such 
understanding. Some may claim that, if one thinks the choices and decisions have such impact, 
then he/she should present objectively-verifiable factual data. However, I think the claim that 
assertions with no visible evidence can be ignored justifies the current situation and lacks a 
critical view of reality. And I think the “choices and decisions of patients or clients” that the 
claim supports would treat the “selection of life” only as a “private matter,” and stand with no 
critical view on the current circumstances that are not supportive enough for people with 
disabilities or incurable diseases, encouraging and reproducing a negative situation. This 
indicates the necessity of paying attention to the context following this line of thought. 
(3) Reflective communication:  
The degree of “seriousness” of genetic diseases or disabilities is often a problem for 
preimplantation diagnosis and prenatal diagnosis to prevent the diseases and accompanying 
disabilities at the stage of reproduction. If a negative test result is expected to lead to terminating 
embryo or fetus, the diagnosis irresistibly involves assessment of life values, namely the 
determination of whether that life is worth living or not. Some say the persons (parents-to-be) 
who actually cares for the child should conduct the assessment and society including the 
government and academic associations as well as third parties should never even enter the 
argument. It is in fact a principle that the selection and decision patients and clients make should 
be respected and supported ultimately, but could any selection and decision be approved as 
“autonomous decision making of the persons involved” or as “reproductive freedom and rights”? 
A reflective communication process, e.g. clinical ethics committee, would be necessary for 
identifying a certain principle and creating an opportunity for careful consideration through the 
repeated exchange of information and opinions, including the seriousness of genetic diseases, 
quality of life and social support systems, between clients and clinical staff. 
(4) Public communication:  
Each decision made in clinical medicine is required to observe the rules (laws or guidelines) 
of the government or academic associations, or even rules of international society if the decision 
involves special themes such as clone technology. Therefore in the process of establishing the 
rules, public opinion, and the various opinions of clients and patients should never be ignored. In 
particular, when the decisions involve intervention in a specific quality of life, objections made 
by people who live with such a quality of life (patients and their families, disabled people and 
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their families) should have significant meaning regardless of whether the public seriously 
approves or disapproves of the objection, or just ignores it. How should we evaluate a social cost 
theory or an eugenic viewpoint which asserts that people who have the causative gene of a 
genetic disease should take a genetic test and should not give birth to a disabled child that will 
raise the social welfare cost, and that if they do decide to have the child, they should care for the 
child without relying on social welfare? Of course, what I mean by “eugenic” is not the 
improvement of genetic quality at the population level conducted by the government, but a new 




3. Decision Making Process as Context: Case Oriented Discussion 
 
In a usual process, patients or clients and their families visit medical institutions with their own 
problems, receive necessary information, and make a decision through various communication 
processes and considerations. Below I present four model cases that lead to such a process for 
making decisions on reproduction, and conduct a context-sensitive study of the cases. 
 
A. Premarital diagnosis 
 
In genetic counseling, there are some cases of people who intend to marry being concerned 
about not only their genetic quality, but also the quality of life of their child-to-be. This issue also 
involves societal conditions and the public concept of values. 
[Case 1] Female in her late 20s. She has several relatives who have probably-congenital 
mental impairments, and suspects that she possesses the causative genes. She has a fiancée and 
worries that she might pass on that impairments to their children. She therefore wants to undergo 
genetic test. If she has the causative genes, she does not want to inform anyone about it and will 
break the engagement without explaining why because the fiancée and his family place 
significance on family lineage and blood line. 
“Family line,” “family lineage” and “blood line” are concepts that prompt special emotions 
regarding “inheritance,” and are deeply inherent in Japanese culture and customs. Expressions 
such as “shame on the family” or “person with ambiguous origin” imply the thought that “we do 
                                                 
2  cf. Shimoda, M., Designing Life and New Eugenics, in: Challenges for Bioethics from Asia, Eubios 
Ethics Institute, ed. by D.R.J. Macer, pp.312-318, Nov. 2004; Paul, D. Genetic Services, Economics, and 
Eugenics, Social Context, 1998;11(3-4):481-491; Resta, R.G., Eugenics and Nondirectiveness in Genetic 
Counseling, Journal of Genetic Counseling, 1997;6(2):255-258; Resta, R.G., Eugenic Considerations in the 
Theory and Practice of Genetic Counseling, Social Context, 1998;11(3-4):431-438. 
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not want to introduce strange genes into our family.” “Strange genes” mean in most cases genes 
that may induce genetic diseases or mental, intellectual or physical impairments. These views of 
heredity are criticized in principle as discrimination and biased views, but when people are 
actually party to such cases, most of them approve those views, believing that “fundamentally 
everyone must hold such views.” The stigma of a woman who “may bear a child with inherited 
intellectual impairment” could induce her strong anxiety and fear of discrimination and biased 
views, while she might accept it as an “inevitable fact” and make an autonomous decision to 
withdraw from a marriage. It is now asked whether we should regard this as a “private matter” or 
as “an issue that society as a whole should tackle.” 
 
B. Preconception diagnosis 
 
It is widely approved as a reproductive freedom and right, and as happiness-pursuing rights to 
determine by contraception, birth control, and fertility treatment whether, when, and how to have 
a child. However, whether these rights include that of selecting the quality of life of the child, i.e. 
that of determining what type of child to have remains a controversial issue. Perhaps the answer 
lies in the meaning of the parent’s selection of desired/undesired quality of life of the child-to-be. 
[Case 2] A couple in their 30s, whose first child has an incurable nervous disorder, wish to 
have a second child. They came for genetic counseling to ask about the risk of the second child 
developing the same disease. They state that they would abandon conception if the risks are high. 
Although they love and care for their child with the incurable disease, they could not do the 
same for another child, and therefore they hope to be able to have a healthy child. 
Through the care for their child with the incurable diseases, the parents might have 
experienced the warm/cold stares of people, the effectiveness/insufficiency of social support 
systems, and the value/problems of the parents’ association and parties involved. They could 
make a decision by stepping back from the dominant concept of societal values, and we should 
take their decision seriously. Nevertheless the selection of quality of life and the context behind 
the selection must be examined independently from their intents amd circumstances. In 
particular, we have to carefully assess the social impact of views such as “caring for a child with 
an incurable disease is tough” and the “actual experience of the party involved should be 
respected.” 
Here we should pay attention to the fact that the genetic makeup of “the one who has not 
been born yet” is used as information for life planning of the parents-to-be, and that the meaning 
of the existence of the unborn baby is determined by the parents. This fact indicates the 
possibility of enhancing and strengthening the desire for others who are controllable, namely the 
desire that they should be exactly what we hope for and should not be something that will bother 
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or trouble us. 
 
C. Preimplantation diagnosis and embryo selection 
 
Preimplantation diagnosis is a method to examine the risk of a specific genetic disorder by 
collecting cells from in vitro-fertilized embryos and conducting various genetic tests. Usually 
“normal” embryos are selected according to the test result and placed back in the uterus for 
conception and birth, while “abnormal” embryos are frozen or disposed of. The selection 
patterns can be classified into two types: “negative or avoiding” and “positive or desiring.” The 
former includes sex selection to prevent X-linked heredity diseases, the prevention of 
chromosome abnormality due to habitual miscarriage and late pregnancy, and the prevention of a 
person with a genetic disease or causative disease from passing on such problems to their 
children. The latter includes sex selection for non-medical purpose, donor baby for therapeutic 
purposes (e.g. having a sibling by selecting a high-histocompatibility embryo to conduct 
umbilical cord blood transplant for an elder brother/sister with leukemia), and having a child 
who has the same function or form as parents with deafness or achondroplasia.  
[Case 3] A couple in their 30s, whose first child has an incurable disease due to a 
chromosome abnormality, want to have a second child. They came for genetic counseling to ask 
about the risk of the second child developing the same disease. If the risk is high, they want to 
undergo in vitro fertilization and conduct genetic test to select an embryo with no possibility of 
disease for conception and birth of a child. 
Some approve of the selection in such cases because of the lack of other methods, 
compelling reasons of the parents, and the hope of having a healthy child. Namely, they 
emphasize individual freedom of choice or the right to pursue happiness. On the other hand, 
some disagree with the notions of the “selection” and the “happiness” in view of equality of life 
values, claiming that the selection should not be made arbitrarily and that having an incurable 
disease or disability should not be recognized as an unhappy state. The client of case 3, however, 
may not be concerned with this kind of conflict, often observed in medical research and clinical 
medicine that intervene in the quality of life.  
The Japan Society of Obstetrics and Gynecology stated in its bulletin “Remarks on 
preimplantation diagnosis” (revised in 1999) that the preimplantation diagnosis should only be 
used for serious genetic diseases and the condition of “serious” genetic disease should be 
examined in individual cases because of divided views on the condition. The client would also 
not be concerned with the public communication that discusses whether regulation with a 
uniform standard in a law or guideline is appropriate or not, and whether each medical institution 
should create their own guidelines or not. 
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Nonetheless, I think it absolutely vital to provide clients with an opportunity to reflect their 
intent, and to provide medical personnel and, if necessary, non-medical experts and the parties 
involved, with an opportunity for discussing the conflict between the freedom of choice or the 
rights for pursing happiness and the equality of life values, and for assessing how “serious” the 
genetic disease is. This is because decisions and agreements made in individual clinical medicine 
are not final and should be updated constantly in a communication process for reflection.  
 
D. Prenatal diagnosis and selective abortion 
 
Many research results on this topic have been accumulated inside and outside the country 
particularly in connection with “disability.” In this section, I would like to limit our view to the 
context of public communication for discussing medical tests that may result in selective 
abortion.  
[Case 4] Female in her late 30s. She saw a poster in a hospital when she was pregnant and 
asked for a maternal serum marker screening. The result was positive and she was recommended 
by a physician to have amniocentesis. She became worried and studied related matters on the 
Internet. She is now thinking of having a genetic test of embryonal or fetal cells. She and her 
husband have decided to terminate pregnancy if any abnormality is found. 
In the report on prenatal diagnosis “Remarks on maternal serum marker screening” 
submitted in 1999 by advisory panel to the Health and Welfare Minister, medical doctors are 
requested not to recommend the test but to conduct it with a sufficient explanation only if 
consulted by pregnant women, under the current circumstances in which there is concern about 
the test conducted without full understanding of its meaning as well as about insufficient 
specialized counseling systems. Some may say patients or clients have the right to choose 
whether they should take a genetic test and other various medical tests to obtain data necessary 
for making a selection, and that the government, academic associations, and medical institutions 
should not limit that right. Also, the client in case 4 may be embarrassed by the reason, for which 
the report suggested restricting the use of the test, that “a part of the technology might lead to the 
elimination of fetuses with impairments and to the denial of respect for the right to live and the 
life of disabled people.” On the contrary, if the government or specialist groups take a clear 
stance of creating policy to promote the prevention of the birth of impaired children, and even if 
the birth prevention is not forced but promoted based on client’s spontaneous choice, the social 
trend that “everyone should have prenatal diagnosis and it is irresponsible to give birth to a 
impaired child without having the diagnosis in advance" could become stronger and invisible 
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pressure would be placed upon people.3 
The parents-to-be may think it questionable to claim their compelling demand would lead to 
denying the human rights of disabled people and it not reasonable to intervene in their right of 
choice for such unjustified reasons. Still, we should not overlook the inevitable involvement and 





Adult presymptomatic diagnosis has often been conducted in genetic counseling in recent years. 
Some problems have been pointed out in the diagnosis such as conflict between the client’s 
privacy right and the relative’s right to know, and the client’s right “not to know” about incurable 
diseases. We can regard the problems as a context of the autonomy, adequacy and limit of an 
individual’s choice and decision, although further discussion of this is not pursued here. 
There is, in the name of “reproductive freedom and rights,” a move to approve not only 
assisted reproductive technologies, but also preimplantation diagnosis and embryo selection, 
prenatal diagnosis and selective abortion, surrogate birth, and even the production of cloned 
humans.4 Supporters of this movement regard the freedom and right of choice based on the 
client’s autonomy as a “private matter” of life planning and the pursuit of happiness. As 
discussed in the above, however, we should not overlook the fact that individual assessment, 
judgment, choice, and decision could reflect, support, strengthen, perpetuate, and reproduce the 
social concept of values in the network (= context) of desires such as “those who may bother or 
trouble others should be eliminated if possible” and “any child we have should be the one that 
we wish for.” Not only medical personnel, patients, and clients, but also the public could 
deliberate and reflect by recognizing the context of emotion and intent expressed in individual 
clinical medicine. 
 
© 2006 by Motomu SHIMODA. All rights reserved. 
                                                 
3  cf. Wertz, D., Eugenics is Alive and Well: A Survey of Genetic Professionals around the World, Social 
Context, 1998;11(3-4):493-510. 
4  cf. Robertson, J.A., Children of Choice: Freedom and the New Reproductive Technologies, Princeton 
U.P., 1994; Harris, J., Rights and Reproductive Choice, in: J. Harris and S. Holm(eds.), The Future of 
Human Reproduction, Clarendon Press, 1998. 
 
